Introduction {#sec1-1}
============

Colorectal cancer (colon and rectum) is a common disease with different incidence in different areas of the world and is considered as a health problem in communities (Ansari et al., 2007; Khazaei et al., 2015). Despite of remarkable advances in medical sciences, cancer is an important disease and the second cause of death after cardiovascular diseases (Farzianpour et al., 2014; Jafari et al., 2015; Khazaei et al., 2016; Moradi et al., 2016). The results of different genetic, experimental, and epidemiological studies indicated that colorectal cancer develops as a result of mutual effects of genetic talent, environmental factors, and lifestyle (Ansari et al., 2007; Shadmani et al., 2017). The commonest symptoms in patients with colorectal cancer include stomachache, change in bowel habits, bleeding from rectum, weakness, anemia, and weight loss (Ford et al., 2008).

There have been reported 4,000 new cases of colorectal cancer and 1,150 deaths from it in Iran every year (Moradi et al., 2009). The age specific rate among women and men in Iran is 8.1 and 7.6 per 100,000; respectively (Akhoond et al., 2010). The prevalence of colorectal cancer is increasing in Asian and Western countries (Ponz de Leon et al., 2004). There has been a steady increase in colorectal cancer in Europe (Ponz de Leon et al., 2004; Sung et al., 2005) while in the US, the trend is increasing (Zheng et al., 2014). About 143,460 new cases of colorectal cancer are diagnosed in the United States every year. Approximately 51,690 Americans die of colorectal cancer every year, which accounts for 9% of all deaths caused by cancer in the United States (Jemal et al., 2013). Globally, progression of colorectal cancer is different, and this difference is over 10%. The highest rate of prevalence is related to Australia, New Zealand, Europe, and North America and the lowest to Africa and Central and South Asia. The prevalence rate of colorectal cancer in Iran is lower than Western Countries (Akhoond et al., 2010). It seems that geographical differences can lead to differences in diet and environment, which are obtained aster a background of genetic talent (Jemal et al., 2011). Incidence of colorectal cancer in ages below 40 years is not common. In Western countries, only 2-8% of all colorectal cancer cases occur in under-40 individuals while this figure is 15-35% in Middle Eastern countries and 17% in Iran (Angell-Andersen et al., 2004). This high rate of prevalence of colorectal cancer among young people is attributed to the age structure of the young in these countries and the rate of prevalence among the elderly compared to Western countries (Ansari et al., 2007). The reported 5-Year survival in Europe is 56% for men and 60% for women (Angell-Andersen et al., 2004; Omejc et al., 2004) \[In their study conducted in England, Anwar et al., (2012) reported 5-year survival rate to be 50%. Farzianpour et al., (2013) indicated that the general quality of life among patients with cancer is low in Iran. Hosseini et al., (2014) carried out a review of clinical and pathological features and survival rate among 37,901 patients and reported 5-year survival rate to be 52.2%. Abbasi Asl et al., (2015) analyzed survival rate of patients with colorectal and prognostic factors and determined 1- and 5-year survival rates as 79.2 and 39.6 percent, respectively. Akhond et al., (2010) studied the effective factors on survival rate of patients with colon and rectum cancer and reported 1-, 2-, 3-, 4-, and 5-year survival rates of patients with colon cancer as respectively 88.7, 77.9, 68.5, 61.4, and 56.8 and for those with rectum cancer as 89.1, 74.2, 60.7, 47.1, and 41.9, respectively.

Survival rate in western countries has taken an increasing trend as a result of accurate diagnosis methods and prevention of tumor progression; therefore, the rate of mortality caused by cancer has dropped (Abbasi Asl et al., 2015). Recent studies indicated that colorectal cancer in Iran has remarkably increased, which is attributed to the change in lifestyle, tendency of diet toward western style, and advances in diagnosis methods (Ansari et al., 2007). Early diagnosis of this cancer in highly important because it is one of the most curable diseases if diagnosed early, and a major part of incidence of colorectal cancer is related to amendable diagnostic factors (Parsaee et al., 2015).

There are different results for the impacts of effective factors and survival rate of colon and rectum cancers in different studies. It is necessary to evaluate the total survival rate and the effect of clinical factors on colorectal cancer in order to inform the community to quickly refer to doctor and conduct examinations. Since meta-analysis is an important approach for combining the results (Moosazadeh, 2013; Moosazadeh et al., 2013) the present study was carried out in order to measure the survival rate of patients with colorectal cancer in Iran through meta-analysis.

Materials and Methods {#sec1-2}
=====================

Search strategy {#sec2-1}
---------------

To find the articles in the present study, prestigious national databases like SID, Magiran, and Irandoc and international ones such as PubMed, Google Scholar, Scopus, and Science Direct were visited and keywords like Iran, survival rate, rectum, colon, colorectal cancer, and their Persian equivalent were utilized. Moreover, the references of the articles were also employed to make sure about retrieving the whole articles. Electronically published articles over December 2007 and March 2015 were extracted.

Choosing the articles {#sec2-2}
---------------------

All of the articles that studied the survival rate in colorectal, rectum, and colon cancers were included in the study without any restrictions. Repetitive and irrelevant cases were crossed out after their title, abstract and full text were examined. Moreover, in order to prevent the bias caused by republishing (transverse and longitudinal publication bias), the results of the studies published in 2 journals were utilized and one of them was crossed out.

Quality evaluation {#sec2-3}
------------------

To evaluate the quality of the selected articles, an inventory that was used in previous studies was employed (Moosazadeh et al., 2014). This inventory was developed by examining STROBE checklist (Von Elm et al., 2007) statement and composed of 12 questions that cover different aspects of methodology including determination of proper sample size, the type of the study, sampling method, study population, data collection method, definition of the variables, the method of examining the samples, data collection instruments, statistical tests, study objectives, presentation of the findings in an appropriate form, and presentation of the results according to the study objectives. Each question was given one score, and any study that received a minimum of 9 scores (Moosazadeh et al., 2014) was included for meta-analysis.

Inclusion criteria {#sec2-4}
------------------

All of the English and Persian articles that had determined 1-, 2-, 3-, 4-, and 5-year survival rates and gained the required score during quality evaluation were chosen.

Exclusion criteria {#sec2-5}
------------------

Studies that had not determined the survival rate and did not have enough data, abstracts whose full text format was not provided, articles whose sample size was not specified, articles that did not obtain the minimum evaluation score, and those that were case report, experimental-control group type, and interventional were crossed out.

Data extraction {#sec2-6}
---------------

The data of each article were extracted based on the study title, the first author, the study year, the study location, sample size, 1-, 2-, 3-, 4-, 5-, 7-, and 10-year survival rates, the significance level of the relationship between colorectal cancer survival rate and the variables of degree of cellular differentiation, type of morphology, family background, BMI, smoking background, alcohol consumption, age, gender, disease stage, tumor metastasis, metastasis to nearby lymph nodes, the type of the first treatment, tumor location, marital status, and the extent of penetration into intestinal wall. Moreover, two of the researchers registered the collected data into Excel.

Analysis {#sec2-7}
--------

Stata Software was utilized to analyze the collected data. In the present study survival rate was examined among 15,877 colorectal cancer cases. In studies where the size of the female and male samples were registered separately, 8,688 men and 5,348 women participated. The median of survival rate ranged from 7.75 in the study conducted by Akhond et al., (2010) to 95.53 in the one carried out by Moghimi Dehbokri et al., (2008). Meta-regression test indicated that there was a significant relationship between cancer location and survival rate. According to the results of this test, the survival rate of rectum cancer was 41.9 times higher than that colon cancer, and that of colon cancer was 41.9 units more than those with colorectal cancer (colon and rectum were considered in one unit) (P-value\<0.001, β =41.9).

The results of the Systematic research {#sec2-8}
--------------------------------------

The initial search in national and international databases led to finding 19,530 documents which decreased to 2,076 after the search strategy was changed and the features increased. By examining the title and summary of the articles, the number of the articles became 484. Moreover, 270 cases were crossed out due to the overlap among the databases. Afterwards, the full text version of 214 articles were considered for examining inclusion and exclusion criteria, which led to crossing out 185 cases that were not relevant or did not possess inclusion criteria. Moreover, 4 articles were retrieved by reviewing the references. Finally 28 articles (Zampino, 2004; Birgisson et al., 2005; Ansari et al., 2007; Moghimi et al., 2008; Asghari-Jafarabadi et al., 2009; Mehrkhani et al., 2009; Moradi et al., 2009; Razavi et al., 2009; Akhoond et al., 2010; Nasiri et al., 2010; Safaee et al., 2010; Karimi Zarchi et al., 2011; Tabatabaie et al., 2011; Esna-Ashari et al., 2012; Mehrabani et al., 2012; Saki Malehi et al., 2012; Abadi et al., 2013; Aryaie et al., 2013; Fekri, 2013a; Heidarnia et al., 2013; Omidvari et al., 2013; Sanei, 2013; Ahmadi et al., 2014; Akhavan et al., 2014; Gohari, 2014; Roshanaei et al., 2014; Vakili et al., 2014; Abbasi Asl, 2015; Parsaee et al., 2015) were considered for meta-analysis and systematic review (See [Figure 1](#F1){ref-type="fig"}). Moreover, 3 articles (Asghari-Jafarabadi et al., 2009; Akhoond et al., 2010; Asghari Jafarabadi et al., 2013) were entered the study twice because they had reported survival rate of rectum and colon cancers separately.

![Search Procedure and Selection of the Initial Studies](APJCP-19-3009-g001){#F1}

###### 

The Properties of the Initial Studies Included in Meta-analysis in Relation with the Survival Rate of Colorectal Cancer

  Id   First author         publication year   Sample size   age average   Primary tumor site   Mean Survival   Median Survival   Overall Survival Rates,%                           
  ---- -------------------- ------------------ ------------- ------------- -------------------- --------------- ----------------- -------------------------- ------- ------- ------- -------
  1    Moghimi Dehkordi     2008               1127          53.59         Colorectal           105.1           95.53             91.1                       \-\--   73.1    \-\--   61
  2    Mehrabani            2012               243           \-\--         Colorectal           \-\--           36.06             9309                       \-\--   50.3    \-\--   27.2
  3    Vakili               2014               604           58.9          Colorectal           77.50           60                72.2                       \-\--   \-\--   \-\--   50.1
  4    Tabatabai            2011               26            56            Colorectal           \-\--           \-\--             48                         \-\--   \-\--   \-\--   43
  5    Saki Malehi          2012               739           59.7          Colorectal           42.46           22.8              \-\--                      \-\--   \-\--   \-\--   63.3
  6    Roshanai             2014               169           \-\--         Colorectal           \-\--           40                89                         \-\--   54      \-\--   31
  7    Moradi               2009               2192          \-\--         Colorectal           \-\--           \-\--             84                         68      54      43      41
  8    Mehrkhani            2009               1090          \-\--         Colorectal           42.84           44.3              72                         \-\--   54      \-\--   47
  9    Heidarnia            2013               559           63            Colorectal           \-\--           \-\--             \-\--                      \-\--   \-\--   \-\--   68.3
  10   AsnaAshari           2009               2342          58.13         Colorectal           \-\--           \-\--             \-\--                      \-\--   \-\--   \-\--   47.36
  11   Abasiasl             2015               88            56.6          Colorectal           \-\--           38.8              79.2                       \-\--   \-\--   \-\--   39.6
  12   Ansari               2007               237           58.15         Colorectal           \-\--           \-\--             80                         \-\--   \-\--   \-\--   49
  13   Parsaee              2015               241           56.62         Colorectal           3.09            39.35             81                         66      53      44      \-\--
  14   Nasiri               2010               109           50.5          Colorectal           42.8            44.3              72                         \-\--   54      \-\--   47
  15   Ahmadi               2013               1127          53.5          Colorectal           \-\--           68.83             \-\--                      \-\--   \-\--   \-\--   \-\--
  16   Aryaie               2013               227                         Colorectal           43.4            42.8              \-\--                      \-\--   \-\--   \-\--   \-\--
  17   Gohari               2014               724           53.03         Colorectal           \-\--           104               \-\--                      \-\--   \-\--   \-\--   \-\--
  18   Safaee               2010               110           \-\--         Colorectal           91.51           48.6              92.6                       \-\--   80.1    \-\--   41.3
  19   Karimi Zarchi        2011               241           59.7          Colorectal           56.5            \-\--             \-\--                      \-\--   \-\--   \-\--   \-\--
  20   Akhond               2010               1194          \-\--         Colon                \-\--           7.75              88.7                       77.9    68.5    61.4    56.8
  21   Razavi               2009               91            \-\--         Colon                \-\--           \-\--             \-\--                      \-\--   \-\--   \-\--   \-\--
  22   Fekri                2013               131           57.36         Colon                36.03           43.73             76                         62      56      44      \-\--
  23   Asghari Jafarabadi   2013               67            \-\--         Colon                \-\--           \-\--             82.6                       \-\--   58.51   \-\--   46.79
  24   Asghari Jafarabadi   2009               817           53.56         Colon                111.82          \-\--             91.7                       83.7    75.9    69      63.3
  25   Ababi                2013               580           \-\--         Colon                \-\--           \-\--             \-\--                      \-\--   \-\--   \-\--   67.06
  26   Akhond               2010               1194          \-\--         Rectum               \-\--           3.917             89.1                       74.2    60.7    47.1    41.9
  27   Asghari Jafarabadi   2013               27            \-\--         Rectum               \-\--           \-\--             91.52                      \-\--   76.65   \-\--   65.58
  28   Asghari Jafarabadi   2009               402           55.3          Rectum               135.95          \-\--             96                         91.2    84      78.2    76
  29   Akhavan              2014               119           \-\--         Rectum               \-\--           \-\--             97                         \-\--   88      \-\--   55
  30   Omidvari             2013               153           57.15         Rectum               \-\--           \-\--             \-\--                      \-\--   \-\--   \-\--   53.4
  31   Sanei                2013               101           \-\--         Rectum               64.45           72                \-\--                      \-\--   \-\--   \-\--   \-\--

Results {#sec1-3}
=======

Degree of cellular differentiation {#sec2-9}
----------------------------------

Six studies (Ansari et al., 2007; Akhoond et al., 2010) (Moghimi et al., 2008; Mehrkhani et al., 2009; Nasiri et al., 2010; Saki Malehi et al., 2012) reported that there was a significant relationship between survival rate of patients with colorectal cancer and degree of cellular differentiation, such that patients with higher differentiation degree had the highest survival rate and those with lower differentiation degree had the lowest survival rate.

Morphology type {#sec2-10}
---------------

Three articles (Moghimi et al., 2008; Saki Malehi et al., 2012; Roshanaei et al., 2014) reported that there is a significant relationship between morphology and survival rate in a way that the morphology of tumor has been introduced as a prognostic factor for colorectal cancer (Saki Malehi et al., 2012).

Family background {#sec2-11}
-----------------

Three articles (Moghimi et al., 2008; Safaee et al., 2010; Ahmadi et al., 2014) reported that there is a relationship between family background and survival rate. For example the study of Ahmadi et al., (2014) showed that 36.8% of the patients with colorectal cancer had positive family background.

BMI {#sec2-12}
---

Four studies (Moghimi et al., 2008; Asghari-Jafarabadi et al., 2009; Akhoond et al., 2010; Omidvari et al., 2013) reported that there is a relationship between BMI and survival rate in a way that patients with a BMI lower than 18.5 had a shorter survival time (Asghari-Jafarabadi et al., 2009).

###### 

Evaluation of Survival Rate of Patients with Colorectal Cancer in Iran Through Meta-analysis

  survival     Percent of survival   Heterogeneity          
  ------------ --------------------- --------------- ------ ---------
  One year     85 (82-88)            452.02          95.8   \<0.001
  Two year     75.1 (68.2-81.9)      240.1           97.5   \<0.001
  Three year   65 (59-71)            505.9           97     \<0.001
  Four year    55.4 (45.1-65.7)      397.7           98.5   \<0.001
  Five year    52 (47-56)            709.4           96.9   \<0.001

Smoking background {#sec2-13}
------------------

Four studies (Ansari et al., 2007; Moghimi et al., 2008; Vakili et al., 2014; Parsaee et al., 2015) reported that there is a relationship between smoking background and survival rate. The mortality risk of smoking patients was 3.356 times more than non-smoking ones (Parsaee et al., 2015).

![One-year Survival](APJCP-19-3009-g002){#F2}

![Three-year Survival](APJCP-19-3009-g003){#F3}

![Five-year Survival](APJCP-19-3009-g004){#F4}

Alcohol consumption {#sec2-14}
-------------------

Three articles reported a relationship between alcohol consumption and survival rate (Akhoond et al., 2010; Mehrabani et al., 2012; Fekri N, 2013b) in a way that survival rate in the non-alcoholic group was significantly higher than the patients who had alcohol consumption background (Mehrabani et al., 2012).

Age {#sec2-15}
---

Twelve studies (Ansari et al., 2007; Moghimi et al., 2008; Mehrkhani et al., 2009; Nasiri et al., 2010; Safaee et al., 2010; Tabatabaie et al., 2011; Mehrabani et al., 2012; Saki Malehi et al., 2012; Abadi et al., 2013; Omidvari et al., 2013; Roshanaei et al., 2014; Vakili et al., 2014) reported a relationship between age and survival rate of patients with colorectal cancer in a way that 11.8% of patients with colorectal cancer were under 40 years old at the time of diagnosis (Ansari et al., 2007).

Gender {#sec2-16}
------

Six articles (Ansari et al., 2007; Moghimi et al., 2008; Safaee et al., 2010; Tabatabaie et al., 2011; Mehrabani et al., 2012; Vakili et al., 2014) indicated that there is relationship between gender and survival rate of the patients in a way that the number of male patients was more than female ones, and women's diagnosis age of patients was lower than men's (Ahmadi et al., 2014; Norouzirad et al., 2017).

Disease stage {#sec2-17}
-------------

A significant relationship was reported between disease stage and survival rate of the patients in 8 articles (Ansari et al., 2007; Moghimi et al., 2008; Asghari-Jafarabadi et al., 2009; Mehrkhani et al., 2009; Nasiri et al., 2010; Saki Malehi et al., 2012; Fekri N, 2013a; Parsaee et al., 2015) such that in a stage that there is distant metastasis, the lowest survival rate was observed (Ansari et al., 2007). The mortality risk of patients in stage III was 5.043 times than that of those in stage I. Moreover, the mortality risk for patients in stage II was 1.148 times higher than those in stage I. And, the mortality risk of patients in stage II was 1.036 times higher than those in stage I (Ansari et al., 2007).

Tumor metastasis {#sec2-18}
----------------

Eight articles (Moghimi et al., 2008; Asghari-Jafarabadi et al., 2009; Akhoond et al., 2010; NASIRI et al., 2010; Mehrabani et al., 2012; Omidvari et al., 2013; Roshanaei et al., 2014; Abbasi Asl, 2015) reported a relationship between tumor metastasis and survival rate of the patients in a way that the mortality risk of individuals with metastasis who have referred to other centers was 3.26 times more that those without it (Abbasi Asl, 2015). The study conducted by Akhond et al., (2010) reported that the mortality risk of individuals with tumor metastasis that referred to other centers was 3.577 for colon cancer and 2.646 for rectum cancer compared to those without it.

Metastasis to nearby lymph nodes {#sec2-19}
--------------------------------

The relationship between metastasis to nearby lymph nodes and survival rate of the patients is mentioned in 3 articles (Moghimi et al., 2008; Tabatabaie et al., 2011; Saki Malehi et al., 2012) in a way that there was a significant relationship between presence of various metastases and a reduction in survival rate of patients (Tabatabaie et al., 2011). Patients with more metastases had a lower 1-year survival rate (Tabatabaie et al., 2011).

First treatment type {#sec2-20}
--------------------

Five articles (Moghimi et al., 2008; Asghari-Jafarabadi et al., 2009; Akhoond et al., 2010; Mehrabani et al., 2012; Abbasi Asl, 2015) reported a relationship between first treatment type and survival rate of the patients in a way that first treatment type affects the improvement in the patients' survival, and the patients insistence in order to complete the treatment stages and also supplement medicines can be effective in enhancing the survival rate of the patients(Abbasi Asl, 2015).

Tumor location {#sec2-21}
--------------

A significant relationship between survival rate and tumor location was reported in 3 articles (Ansari et al., 2007; Safaee et al., 2010; Mehrabani et al., 2012) in a way that comparing 1-year survival rate with different involved locations indicates that the lowest survival rate is observed among patients with rectum and recto-sigmoid (Ansari et al., 2007).

Marital status {#sec2-22}
--------------

Three articles (Moghimi et al., 2008; Asghari-Jafarabadi et al., 2009; Mehrabani et al., 2012) were reported a relationship between marital status and survival rate of the patients.

The Extent of penetration into intestinal wall {#sec2-23}
----------------------------------------------

Two articles (Moghimi et al., 2008; Nasiri et al., 2010) showed that there is a relationship between the extent of penetration into intestinal wall and survival rate of the patients.

Discussion {#sec1-4}
==========

In the present meta-analysis, the 1-, 2-, 3-, 4-, and 5-yearsurvival rate of colorectal cancer was respectively 85, 75.10, 65, 55.40, and 52. The results indicated that anatomic location of tumor had a significant effect on survival rate. According to the results of this examination, survival rate of the patients with rectum was 41.9 units more than those with colon, and the survival rate of those with colon was 41.9 units more than those with colorectal cancer (colon and rectum were considered as one unit). The results of the study carried out by Birgisson et al., (2005) in Sweden indicated that 5-year survival rate for colon and rectum cancers were respectively 57.2 and 57.6%. Labianca et al., (2004) and Zampino et al., (2004) presented similar results for colon and rectum cancers, respectively. In their study in England, van der Pool et al., (2012) reported 5-year survival rate to be over 50%. Mitry et al., (2005) carried out a study in France and reported 5-year survival rate as 56.3%. Ansari et al., (2007) indicated 5-year survival rate with involvement of different places in colon and observed the lowest survival rate in patients with rectum involvement. Rectum tumors are more accessible and show more symptoms; therefore, they are quicker to diagnose. The results of the study carried out by Rosenberg et al., (2008) indicated that rectum tumors had worse prognosis compared to colon tumors.

Degree of cellular differentiation is a significant diagnostic factor for colon cancer. Survival rate of patients whose tumors were differentiated well was 2.7 times more than those whose tumors were poorly differentiated (Asghari-Jafarabadi et al., 2009). Liang et al., (2006) reported a significant relationship between survival rate of patients with colon cancer and the degree of differentiation. Park et al., (1999) concluded that tumor degree had a stronger relationship with rectum cancer.

Different studies have reported different results in regard with the relationship between BMI and survival rate of the patients. Asghari-Jafarbadi et al., (2009) reported that individuals with BMI of 25-29.9 have the lowest rate of mortality risk caused by colon and rectum cancers while those with BMI of lower than 18.5 have the highest mortality risk. Murphy et al., (2000) concluded that obesity increases the risk of mortality from colon cancer especially among men. Shibakita et al., (2005) showed that BMIs of below 21 and over 24 are associated with an increase in mortality risk caused by colorectal cancer. Hines et al., (2009) concluded that patients with colon cancer, low weight enhances mortality while high weight and obesity reduces it. The differences between the results of the studies can be attributed to different factors related to survival rate and the selected study population.

Having metastasis is one of the variables that has a significant relationship with survival rate and is considered as one of the most important health problems of the community, and the survival rate of such patients can be improved to some extent through therapeutic methods like chemotherapy (Saletti, 2006). In the study carried out by Liang et al., (2006), metastasis to lymph node is an important factor in survival rate of patients with colon cancer.

The type of the first treatment is one of the effective factors in survival rate of colorectal cancer in a way that the survival of the patients who had received chemotherapy, radiotherapy or immunotherapy was about 2.3 times more than those who had received surgery (Asghari-Jafarabadi et al., 2009). The results of the study carried out by Lang et al., (2009) indicated that treating colon cancer through surgery and rectum cancer through a combined method (surgery, chemotherapy and radiotherapy) were commoner than other treatment methods.

Iran has a young population. The results of the study conducted by Parsaee et al., (2015) indicated that the affliction proportion among the age group below 50 years was 29.3% which is approximately high. The results of the studies carried out in European countries indicated that only lower than 20% of colorectal cancer cases occurred in individuals of below 50 years (Van der Pool et al., 2012). Rebecca et al., (2009) carried out a study in the United States and concluded that there has been an increase in the rate of colorectal cancer among young people aging 20-49 years (Siegel et al., 2009). In some studies conducted in Iran, the minimum age of colorectal cancer was reported 7 years (Yekta, 2004). The high proportion of colorectal cancer among young people can be justified through two main hypotheses: young population and genetic factors because different cancers related to genetic factors have been seen among young people (Ahdami, 2008.; Frankel and D'angelica, 2014).

The results of different studies indicated that the number of men with colorectal cancer is more than women. A study was carried out in England aimed at comparing the incidence of colorectal cancer among women and men, and the results indicated that the incidence among men was 47% more than women (Hayne et al., 2001). On the other hand, the results of another study conducted in the United States indicated that 51.1% of men were afflicted by colorectal cancer, and there was no significant difference between men and women in this regard (Rabeneck et al., 2003). Neagoe et al., (2004) studies Romanian patients. The results of their study indicated that the proportion of male to female patients was more and the gender proportion was 1.51. The hypothesis that the survival of women is higher, which can be attributed to hormonal and immune factors responsible for different rates of colon and rectum cancers among men and women. Due to secretion of steroids, women have a higher survival rate against these two cancers. The results of the study conducted by Ahmadi et al., (2014) indicated that there was a significant difference between men and women in regard with the diagnosis age in a way that women pay more attention to medical care than men and take part in screening programs than men.

The results of some studies confirm an increase in the risk of colorectal cancer caused by smoking more than its effect on rectum cancer (Nagata, 1999; Chao et al., 2000; Giovannucci, 2001). There is the assumption that smoking is an initiator of CRV (Giovannucci, 1994). A study conducted in the United States reported that smoking increases mortality risk after the diagnosis of colorectal cancer (Phipps and Newcomb, 2011). The results of some studies indicated that there is a significant relationship between alcohol consumption and mortality risk in colon cancer. In a prospective study carried out on 6,291 patients over 1985-2005 by Yi et al., (2010) it was concluded that the mortality rate among alcoholic men with colorectal cancer was 4.9 time more than non-alcoholic ones.

Development of colorectal cancer in first-degree relatives can enhance the development risk of this cancer by 2-3 times (Chan and Niedzwiecki, 2008). Fuchs reported that this increase is higher in rectum cancer (Fuchs, 1994). while Mahdavinia et al., (2005) did not observe the effect of family background on right colon cancer. In the study carried out by Ahmadi et al., (2013) the mortality rate in patients with family background of colorectal cancer was more than those without it which can be attributed togr early screening and diagnosis and preventive measures among those with family background.

Among the limitations of the present study, one can refer to the fact that most studies considered colon and rectum cancers as one unit (colorectal cancer) while they need to be taken into account due to physiological and anatomic aspects, environmental carcinogens, genetic mechanism, and subsections of the large intestine, which will result in more precise results.

In conclusion, since the incidence of colorectal cancer in all age groups is lower in Iran than Western countries, it is necessary to design a screening program for colorectal cancer from young ages in Iran compared to Western countries. Administering a screening program not only leads to a reduction in the incidence of colorectal cancer but also improves the total survival. Public education of people and specialized education of doctors in order to diagnose colorectal cancer at early stages of the disease can help the healthcare policymakers and program designers have access to and provide high quality services, diagnose, and treat the patients. Moreover, it is necessary to conduct more specialized and relevant studies in order to determine genetic or environmental causes of cancer such as diet and cultural and behavioral habits at the national level and with different ethnicities.
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